Cargando…

Targeted Multiplexed Selected Reaction Monitoring Analysis Evaluates Protein Expression Changes of Molecular Risk Factors for Major Psychiatric Disorders

BACKGROUND: Extensive research efforts have generated genomic, transcriptomic, proteomic, and functional data hoping to elucidate psychiatric pathophysiology. Selected reaction monitoring, a recently developed targeted proteomic mass spectrometric approach, has made it possible to evaluate previous...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wesseling, Hendrik, Gottschalk, Michael G., Bahn, Sabine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368865/ https://www.ncbi.nlm.nih.gov/pubmed/25539505 http://dx.doi.org/10.1093/ijnp/pyu015

Ejemplares similares

Proteomic Enrichment Analysis of Psychotic and Affective Disorders Reveals Common Signatures in Presynaptic Glutamatergic Signaling and Energy Metabolism
por: Gottschalk, Michael G., et al.
Publicado: (2015)

SERUM BIOMARKERS FOR PSYCHIATRIC DISORDERS
por: Bahn, Sabine
Publicado: (2014)

A brain proteomic investigation of rapamycin effects in the Tsc1(+/−) mouse model
por: Wesseling, Hendrik, et al.
Publicado: (2017)

Cerebrospinal Fluid Inflammatory Cytokine Levels in Patients With Major Psychiatric Disorders: A Multiplex Immunoassay Study
por: Hidese, Shinsuke, et al.
Publicado: (2021)

Integrative proteomic analysis of the NMDA NR1 knockdown mouse model reveals effects on central and peripheral pathways associated with schizophrenia and autism spectrum disorders
por: Wesseling, Hendrik, et al.
Publicado: (2014)

Inflammation and damage-associated molecular patterns in major psychiatric disorders
por: Valiati, Fernanda Endler, et al.
Publicado: (2023)

Quencher-free multiplexed monitoring of DNA reaction circuits
por: Padirac, Adrien, et al.
Publicado: (2012)

The application of selective reaction monitoring confirms dysregulation of glycolysis in a preclinical model of schizophrenia
por: Martins-de-Souza, Daniel, et al.
Publicado: (2012)

Commentary: Targeting the MRI-mapped psychopathology of major psychiatric disorders with neurostimulation
por: Xie, Jia-Xin, et al.
Publicado: (2022)

Genetic risk scores for major psychiatric disorders and the risk of postpartum psychiatric disorders
por: Bauer, Anna E., et al.
Publicado: (2019)

Diagnostic Distribution of Psychiatric Disorders among Korean Young Adults
por: Hwangbo, Ram, et al.
Publicado: (2020)

Psychiatric comorbidities in patients with major depressive disorder
por: Thaipisuttikul, Papan, et al.
Publicado: (2014)

What is the genetic architecture of major psychiatric disorders?
por: Hennah, W., et al.
Publicado: (2021)

Extracellular vesicle approach to major psychiatric disorders
por: Oraki Kohshour, Mojtaba, et al.
Publicado: (2022)

The measurement of KRAS G12 mutants using multiplexed selected reaction monitoring and ion mobility mass spectrometry
por: Norman, Rachel L, et al.
Publicado: (2020)

DISC1 Pathway in Brain Development: Exploring Therapeutic Targets for Major Psychiatric Disorders
por: Kamiya, Atsushi, et al.
Publicado: (2012)

Leveraging genetic overlap between irritability and psychiatric disorders to identify genetic variants of major psychiatric disorders
por: Jung, Kyeongmin, et al.
Publicado: (2023)

Prerequisites for Appropriate Clinical Staging of Major Psychiatric Disorders
por: Kim, Se Hyun
Publicado: (2018)

A polygenic p factor for major psychiatric disorders
por: Selzam, Saskia, et al.
Publicado: (2018)

Role of the gut microbiome in three major psychiatric disorders
por: Borkent, Jenny, et al.
Publicado: (2022)

Transcriptomics and magnetic resonance imaging in major psychiatric disorders
por: Fan, Jing-Wen, et al.
Publicado: (2023)

Bipolar multiplex families have an increased burden of common risk variants for psychiatric disorders
por: Andlauer, Till F. M., et al.
Publicado: (2019)

Phosphoproteomic differences in major depressive disorder postmortem brains indicate effects on synaptic function
por: Martins-de-Souza, Daniel, et al.
Publicado: (2012)

Formulating treatment of major psychiatric disorders: algorithm targets the dominantly affected brain cell-types
por: Fessel, Jeffrey
Publicado: (2023)

On the relation of psychiatric disorder and neural defect
por: Heinrichs, Jan-Hendrik
Publicado: (2014)

Multiplex NanoSPR Molecular Biosensor for Blood Cytokine Monitoring
por: Mirza, Agha Zeeshan
Publicado: (2022)

Genetic tests in major psychiatric disorders—integrating molecular medicine with clinical psychiatry—why is it so difficult?
por: Demkow, U, et al.
Publicado: (2017)

Genetic architecture of 11 major psychiatric disorders at biobehavioral, functional genomic, and molecular genetic levels of analysis
por: Grotzinger, Andrew D., et al.
Publicado: (2022)

Integrating proteomic and clinical data to discriminate major psychiatric disorders: Applications for major depressive disorder, bipolar disorder, and schizophrenia
por: Shin, Dongyoon, et al.
Publicado: (2022)

Synaptic Wnt signaling—a contributor to major psychiatric disorders?
por: Okerlund, Nathan D., et al.
Publicado: (2011)

Unintentional Injuries among Psychiatric Outpatients with Major Depressive Disorder
por: Hung, Ching-I, et al.
Publicado: (2016)

Transdiagnostic time‐varying dysconnectivity across major psychiatric disorders
por: Li, Chao, et al.
Publicado: (2020)

Evaluation of inflammatory markers in major psychiatric disorders: challenges and perspectives
por: Wollenhaupt-Aguiar, Bianca
Publicado: (2023)

Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder
por: Muscatello, Maria Rosaria Anna, et al.
Publicado: (2019)

Patterns of the Diagnosis Prevalence of Psychiatric Disorders in the Population Aged 0–18 Years Based on the Nationwide Insurance Sample Data
por: Lee, Seung Yup, et al.
Publicado: (2020)

A Quantitative Proteomic Profile of the Nrf2-Mediated Antioxidant Response of Macrophages to Oxidized LDL Determined by Multiplexed Selected Reaction Monitoring
por: Kinter, Caroline S., et al.
Publicado: (2012)

System-based proteomic and metabonomic analysis of the Df(16)A(+/−) mouse identifies potential miR-185 targets and molecular pathway alterations
por: Wesseling, H, et al.
Publicado: (2017)

Cerebrospinal fluid neuroplasticity-associated protein levels in patients with psychiatric disorders: a multiplex immunoassay study
por: Hidese, Shinsuke, et al.
Publicado: (2020)

Changes in major psychiatric disorders in children and adolescents from 2001 to 2020: A retrospective single-center study
por: Zheng, Hongyu, et al.
Publicado: (2023)

PSYCHIATRIC REACTIONS IN HYSTERECTOMY
por: Bhatia, M.S., et al.
Publicado: (1990)

Cannot write session to /tmp/vufind_sessions/sess_49r3h6rule52jfuiarddcbhdhm